CII
Capital International Inc Portfolio holdings
AUM
$10.3B
1-Year Return
33.09%
This Quarter Return
+1.89%
1 Year Return
+33.09%
3 Year Return
+130.02%
5 Year Return
+217.83%
10 Year Return
+680.45%
AUM
$10.4B
AUM Growth
-$844M
(-7.5%)
Cap. Flow
-$845M
Cap. Flow
% of AUM
-8.15%
Top 10 Holdings %
Top 10 Hldgs %
23.53%
Holding
311
New
12
Increased
45
Reduced
215
Closed
14
Top Buys
| 1 |
Trip.com Group
TCOM
|
+$47.7M |
| 2 |
Saia
SAIA
|
+$36.9M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
+$27M |
| 4 |
Ryan Specialty Holdings
RYAN
|
+$24.6M |
| 5 |
Nice
NICE
|
+$21.7M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
+$64.3M |
| 2 |
JPMorgan Chase
JPM
|
+$39M |
| 3 |
Microsoft
MSFT
|
+$32.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$29M |
| 5 |
Alibaba
BABA
|
+$29M |
Sector Composition
| 1 | Technology | 23.49% |
| 2 | Healthcare | 15.08% |
| 3 | Financials | 14.64% |
| 4 | Consumer Discretionary | 13.83% |
| 5 | Communication Services | 12.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Toast
TOST
$23.9B
| $1.12M | 0.01% |
+22,500
| New | +$1.12M |
|
277
Paychex
PAYX
$48.3B
| $916K | 0.01% |
8,148
-1,831
| -18% | -$206K |
|
278
Moderna
MRNA
$9.52B
| $898K | 0.01% |
2,333
-388
| -14% | -$149K |
|
|
DNMR
279
DELISTED
Danimer Scientific, Inc.
DNMR
| $877K | 0.01% |
1,342
-36
| -3% | -$23.5K |
|
280
Merck
MRK
$211B
| $872K | 0.01% |
11,604
-9,114
| -44% | -$685K |
|
281
Qualcomm
QCOM
$171B
| $742K | 0.01% |
5,754
+520
| +10% | +$67.1K |
|
282
Webster Financial
WBS
$10.2B
| $605K | 0.01% |
+11,102
| New | +$605K |
|
283
Teladoc Health
TDOC
$1.38B
| $604K | 0.01% |
4,764
-339
| -7% | -$43K |
|
284
Las Vegas Sands
LVS
$37.1B
| $587K | 0.01% |
16,040
| – | – |
|
285
Procter & Gamble
PG
$373B
| $529K | 0.01% |
3,783
-944
| -20% | -$132K |
|
286
Dayforce
DAY
$10.9B
| $506K | ﹤0.01% |
4,492
-1,670
| -27% | -$188K |
|
287
Union Pacific
UNP
$128B
| $419K | ﹤0.01% |
2,136
| – | – |
|
288
State Street
STT
$31.8B
| $408K | ﹤0.01% |
4,810
-263
| -5% | -$22.3K |
|
289
AB InBev
BUD
$116B
| $318K | ﹤0.01% |
5,643
-230
| -4% | -$13K |
|
290
Exelon
EXC
$43.5B
| $318K | ﹤0.01% |
9,234
| – | – |
|
291
Humana
HUM
$32.8B
| $265K | ﹤0.01% |
682
-93
| -12% | -$36.1K |
|
292
Viatris
VTRS
$12.2B
| $255K | ﹤0.01% |
18,855
| – | – |
|
293
Jack Henry & Associates
JKHY
$11.9B
| $254K | ﹤0.01% |
1,546
-214
| -12% | -$35.2K |
|
294
Novo Nordisk
NVO
$241B
| $238K | ﹤0.01% |
4,958
-652
| -12% | -$31.3K |
|
295
Waste Management
WM
$88.3B
| $231K | ﹤0.01% |
1,545
-200
| -11% | -$29.9K |
|
296
Arthur J. Gallagher & Co
AJG
$76.5B
| $216K | ﹤0.01% |
1,456
-248
| -15% | -$36.8K |
|
297
NextEra Energy, Inc.
NEE
$144B
| $201K | ﹤0.01% |
2,559
-350
| -12% | -$27.5K |
|
298
Autodesk
ADSK
$69.3B
| – | – |
-11,094
| Closed | -$3.24M |
|
|
ALLK
299
DELISTED
Allakos
ALLK
| – | – |
-148,487
| Closed | -$12.7M |
|
300
AngloGold Ashanti
AU
$31.3B
| – | – |
-71,781
| Closed | -$1.33M |
|